Collectively, pharmacological blockade of the Shh pathway effectively inhibited the induction of Dio3 in tissues, ameliorated low T3 state, improved systemic glucose metabolic disorders, and preserved muscle mass. The gene discussed is SHH; the disease is metabolic disease.